An infiltration level analysis in CRC patients with alterations in HDAC2 revealed a distinct immune signature associated with lower B-cell and higher macrophage counts, indicating that the presence of HDAC2 could be marginally involved in B-cell development in CRC. Here, HDAC2 is linked to colorectal carcinoma.